As of April 16, 2025, Nuvation Bio (NUVB) has a market cap of $0.69 billion USD. According to our data, Nuvation Bio is ranked No.5548 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.69 B |
-23.13%
|
Dec 31, 2024 | $0.89 B |
76.16%
|
Dec 29, 2023 | $0.51 B |
-21.35%
|
Dec 30, 2022 | $0.64 B |
-77.41%
|
Dec 31, 2021 | $2.85 B |
-27.35%
|
Dec 31, 2020 | $3.93 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() BioNTech
BNTX
|
$23.80 B |
0.001 M
|
![]() Germany
|
![]() Novavax
NVAX
|
$1.03 B |
0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.31 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
Market Cap | = | NUVB Stock Price | * | NUVB Shares Outstanding |
= | $2.02 | * | 0.34 B | |
= | $0.69 B |